Direct Oral Anticoagulants (DOACs) Device Market Size, Share, Trends, & Industry Analysis Report By Product Type, By Disease Indication, By Application, By Patient Demographic, By End User, and By Region

Description

List of Tables

The direct oral anticoagulants device market size is expected to reach USD 64.83 Billion by 2034, according to a new study by Polaris Market Research. The report "Direct Oral Anticoagulants (DOACs) Device Market Share, Size, Trends, Industry Analysis Report: By Product Type, By Disease Indication, By Application, By Patient Demographic, By End User, and By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Direct Oral Anticoagulants (DOACs) Device coagulation devices are specialized diagnostic tools designed to monitor anticoagulation levels in patients using direct oral anticoagulants, ensuring safe and effective therapeutic outcomes. These devices play a critical role in clinical decision-making by providing accurate, real-time insights into coagulation status, particularly in stroke prevention, venous thromboembolism management, and post-surgical care.

They are essential for improving treatment precision, minimizing adverse events, and supporting individualized patient care across hospitals, ambulatory centers, and homecare settings. Advancements in assay sensitivity, device portability, and digital connectivity are enhancing diagnostic efficiency and expanding the utility of these systems in both acute and chronic care pathways. Their integration into routine clinical workflows contributes to better patient outcomes, streamlined monitoring, and overall healthcare cost optimization.

Direct Oral Anticoagulants (DOACs) Device Market Report Highlights

In terms of application, the stroke prevention segment led the market in 2024, primarily due to rising prevalence of atrial fibrillation and other cardiovascular conditions requiring anticoagulation therapy.

In terms of end user, the hospitals are expected to register the highest CAGR during the forecast period, as they serve as the primary healthcare setting for comprehensive management of both acute thrombotic events and chronic anticoagulation requirements.

North America captured the largest revenue share in the DOAC device market in 2024, owing to its sophisticated healthcare infrastructure, high thromboembolic disease burden, and widespread clinical adoption of direct oral anticoagulants across care settings.

The Asia Pacific market is anticipated to demonstrate consistent growth, fueled by increasing healthcare expenditure, greater awareness of coagulation disorders, and a progressive transition toward preventive care and personalized treatment approaches.

A few global key market players include Siemens Healthineers, Abbott Laboratories, Roche Diagnostics, Sysmex Corporation, Instrumentation Laboratory (Werfen), Nihon Kohden Corporation, Diagnostica Stago, Coag-Sense, HemoSonics, Sekisui Medical Co., Ltd., Grifols S.A., and Helena Laboratories Corporation.

Polaris Market Research has segmented the market report on the basis of product type, disease indication, application, patient demographic, end user, and region:

By Product Type Outlook (Revenue, USD Billion, 2020-2034)

Factor Xa Inhibitors

Direct Thrombin Inhibitors

By Disease Indication Outlook (Revenue, USD Billion, 2020-2034)

Atrial Fibrillation

Deep Vein Thrombosis (DVT)

Pulmonary Embolism (PE)

Heart Attacks

Post-Surgical Thromboprophylaxis

Others

By Application Outlook (Revenue, USD Billion, 2020-2034)

Stroke Prevention

Venous Thromboembolism Prevention

Treatment of Acute Thrombotic Events

Long-Term Prophylaxis

Other Application

By Patient Demographic Outlook (Revenue, USD Billion, 2020-2034)

Paediatric

Adult

Geriatric

By End User Outlook (Revenue, USD Billion, 2020-2034)

Hospitals

Ambulatory Surgical Centers

Specialty Clinics

Homecare Settings

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

Canada

Europe

Germany

France

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Product Code: PM5800

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Direct Oral Anticoagulants (DOACs) Device Market Insights

4.1. Direct Oral Anticoagulants (DOACs) Device Market - Market Snapshot
4.2. Direct Oral Anticoagulants (DOACs) Device Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Increasing Global Burden of Thromboembolic Disorders
  - 4.2.1.2. Aging Global Population with High Cardiovascular Risk
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High Cost of Advanced Diagnostic Devices
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Direct Oral Anticoagulants (DOACs) Device Market Trends
4.6. Value Chain Analysis

5. Global Direct Oral Anticoagulants (DOACs) Device Market, by Product Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
5.3. Factor Xa Inhibitors
- 5.3.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Factor Xa Inhibitors, by Region, 2020-2034 (USD Billion)
5.4. Direct Thrombin Inhibitors
- 5.4.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Direct Thrombin Inhibitors, by Region, 2020-2034 (USD Billion)

6. Global Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
6.3. Atrial Fibrillation
- 6.3.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Atrial Fibrillation, by Region, 2020-2034 (USD Billion)
6.4. Deep Vein Thrombosis (DVT)
- 6.4.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Deep Vein Thrombosis (DVT), by Region, 2020-2034 (USD Billion)
6.5. Pulmonary Embolism (PE)
- 6.5.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Pulmonary Embolism (PE), by Region, 2020-2034 (USD Billion)
6.6. Heart Attacks
- 6.6.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Heart Attacks, by Region, 2020-2034 (USD Billion)
6.7. Post-Surgical Thromboprophylaxis
- 6.7.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Post-Surgical Thromboprophylaxis, by Region, 2020-2034 (USD Billion)
6.8. Others
- 6.8.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Direct Oral Anticoagulants (DOACs) Device Market, by Application

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
7.3. Stroke Prevention
- 7.3.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Stroke Prevention, by Region, 2020-2034 (USD Billion)
7.4. Venous Thromboembolism Prevention
- 7.4.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Venous Thromboembolism Prevention, by Region, 2020-2034 (USD Billion)
7.5. Treatment of Acute Thrombotic Events
- 7.5.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Treatment of Acute Thrombotic Events, by Region, 2020-2034 (USD Billion)
7.6. Long-Term Prophylaxis
- 7.6.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Long-Term Prophylaxis, by Region, 2020-2034 (USD Billion)
7.7. Other Application
- 7.7.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Other Application, by Region, 2020-2034 (USD Billion)

8. Global Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
8.3. Paediatric
- 8.3.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Paediatric, by Region, 2020-2034 (USD Billion)
8.4. Adult
- 8.4.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Adult, by Region, 2020-2034 (USD Billion)
8.5. Geriatric
- 8.5.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Geriatric, by Region, 2020-2034 (USD Billion)

9. Global Direct Oral Anticoagulants (DOACs) Device Market, by End User

9.1. Key Findings
9.2. Introduction
- 9.2.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
9.3. Hospitals
- 9.3.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Hospitals, by Region, 2020-2034 (USD Billion)
9.4. Ambulatory Surgical Centers
- 9.4.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Ambulatory Surgical Centers, by Region, 2020-2034 (USD Billion)
9.5. Specialty Clinics
- 9.5.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Specialty Clinics, by Region, 2020-2034 (USD Billion)
9.6. Homecare Settings
- 9.6.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Homecare Settings, by Region, 2020-2034 (USD Billion)
9.7. Others
- 9.7.1. Global Direct Oral Anticoagulants (DOACs) Device Market, by Others, by Region, 2020-2034 (USD Billion)

10. Global Direct Oral Anticoagulants (DOACs) Device Market, by Geography

10.1. Key Findings
10.2. Introduction
- 10.2.1. Direct Oral Anticoagulants (DOACs) Device Market Assessment, By Geography, 2020-2034 (USD Billion)
10.3. Direct Oral Anticoagulants (DOACs) Device Market - North America
- 10.3.1. North America: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
- 10.3.2. North America: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
- 10.3.3. North America: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
- 10.3.4. North America: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
- 10.3.5. North America: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
- 10.3.6. Direct Oral Anticoagulants (DOACs) Device Market - U.S.
  - 10.3.6.1. U.S.: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  - 10.3.6.2. U.S.: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.3.6.3. U.S.: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  - 10.3.6.4. U.S.: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  - 10.3.6.5. U.S.: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
- 10.3.7. Direct Oral Anticoagulants (DOACs) Device Market - Canada
  - 10.3.7.1. Canada: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  - 10.3.7.2. Canada: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.3.7.3. Canada: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  - 10.3.7.4. Canada: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  - 10.3.7.5. Canada: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
10.4. Direct Oral Anticoagulants (DOACs) Device Market - Europe
- 10.4.1. Europe: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
- 10.4.2. Europe: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
- 10.4.3. Europe: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
- 10.4.4. Europe: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
- 10.4.5. Europe: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
- 10.4.6. Direct Oral Anticoagulants (DOACs) Device Market - UK
  - 10.4.6.1. UK: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  - 10.4.6.2. UK: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.4.6.3. UK: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  - 10.4.6.4. UK: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  - 10.4.6.5. UK: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
- 10.4.7. Direct Oral Anticoagulants (DOACs) Device Market - France
  - 10.4.7.1. France: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  - 10.4.7.2. France: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.4.7.3. France: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  - 10.4.7.4. France: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  - 10.4.7.5. France: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
- 10.4.8. Direct Oral Anticoagulants (DOACs) Device Market - Germany
  - 10.4.8.1. Germany: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  - 10.4.8.2. Germany: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.4.8.3. Germany: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  - 10.4.8.4. Germany: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  - 10.4.8.5. Germany: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
- 10.4.9. Direct Oral Anticoagulants (DOACs) Device Market - Italy
  - 10.4.9.1. Italy: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  - 10.4.9.2. Italy: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.4.9.3. Italy: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  - 10.4.9.4. Italy: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  - 10.4.9.5. Italy: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
- 10.4.10. Direct Oral Anticoagulants (DOACs) Device Market - Spain
  - 10.4.10.1. Spain: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  - 10.4.10.2. Spain: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.4.10.3. Spain: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  - 10.4.10.4. Spain: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  - 10.4.10.5. Spain: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
- 10.4.11. Direct Oral Anticoagulants (DOACs) Device Market - Netherlands
  - 10.4.11.1. Netherlands: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  - 10.4.11.2. Netherlands: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.4.11.3. Netherlands: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  - 10.4.11.4. Netherlands: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  - 10.4.11.5. Netherlands: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
- 10.4.12. Direct Oral Anticoagulants (DOACs) Device Market - Russia
  - 10.4.12.1. Russia: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  - 10.4.12.2. Russia: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.4.12.3. Russia: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  - 10.4.12.4. Russia: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  - 10.4.12.5. Russia: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
- 10.4.13. Direct Oral Anticoagulants (DOACs) Device Market - Rest of Europe
  - 10.4.13.1. Rest of Europe: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  - 10.4.13.2. Rest of Europe: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.4.13.3. Rest of Europe: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  - 10.4.13.4. Rest of Europe: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  - 10.4.13.5. Rest of Europe: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
10.5. Direct Oral Anticoagulants (DOACs) Device Market - Asia Pacific
- 10.5.1. Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
- 10.5.2. Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
- 10.5.3. Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
- 10.5.4. Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
- 10.5.5. Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
- 10.5.6. Direct Oral Anticoagulants (DOACs) Device Market - China
  - 10.5.6.1. China: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  - 10.5.6.2. China: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.5.6.3. China: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  - 10.5.6.4. China: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  - 10.5.6.5. China: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
- 10.5.7. Direct Oral Anticoagulants (DOACs) Device Market - India
  - 10.5.7.1. India: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  - 10.5.7.2. India: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.5.7.3. India: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  - 10.5.7.4. India: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  - 10.5.7.5. India: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
- 10.5.8. Direct Oral Anticoagulants (DOACs) Device Market - Malaysia
  - 10.5.8.1. Malaysia: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  - 10.5.8.2. Malaysia: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.5.8.3. Malaysia: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  - 10.5.8.4. Malaysia: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  - 10.5.8.5. Malaysia: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
- 10.5.9. Direct Oral Anticoagulants (DOACs) Device Market - Japan
  - 10.5.9.1. Japan: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  - 10.5.9.2. Japan: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.5.9.3. Japan: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  - 10.5.9.4. Japan: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  - 10.5.9.5. Japan: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
- 10.5.10. Direct Oral Anticoagulants (DOACs) Device Market - Indonesia
  - 10.5.10.1. Indonesia: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  - 10.5.10.2. Indonesia: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.5.10.3. Indonesia: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  - 10.5.10.4. Indonesia: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  - 10.5.10.5. Indonesia: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
- 10.5.11. Direct Oral Anticoagulants (DOACs) Device Market - South Korea
  - 10.5.11.1. South Korea: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  - 10.5.11.2. South Korea: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.5.11.3. South Korea: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  - 10.5.11.4. South Korea: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  - 10.5.11.5. South Korea: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
- 10.5.12. Direct Oral Anticoagulants (DOACs) Device Market - Australia
  - 10.5.12.1. Australia: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  - 10.5.12.2. Australia: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.5.12.3. Australia: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  - 10.5.12.4. Australia: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  - 10.5.12.5. Australia: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
- 10.5.13. Direct Oral Anticoagulants (DOACs) Device Market - Rest of Asia Pacific
  - 10.5.13.1. Rest of Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  - 10.5.13.2. Rest of Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.5.13.3. Rest of Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  - 10.5.13.4. Rest of Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  - 10.5.13.5. Rest of Asia Pacific: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
10.6. Direct Oral Anticoagulants (DOACs) Device Market - Middle East & Africa
- 10.6.1. Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
- 10.6.2. Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
- 10.6.3. Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
- 10.6.4. Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
- 10.6.5. Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
- 10.6.6. Direct Oral Anticoagulants (DOACs) Device Market - Saudi Arabia
  - 10.6.6.1. Saudi Arabia: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  - 10.6.6.2. Saudi Arabia: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.6.6.3. Saudi Arabia: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  - 10.6.6.4. Saudi Arabia: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  - 10.6.6.5. Saudi Arabia: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
- 10.6.7. Direct Oral Anticoagulants (DOACs) Device Market - UAE
  - 10.6.7.1. UAE: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  - 10.6.7.2. UAE: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.6.7.3. UAE: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  - 10.6.7.4. UAE: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  - 10.6.7.5. UAE: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
- 10.6.8. Direct Oral Anticoagulants (DOACs) Device Market - Israel
  - 10.6.8.1. Israel: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  - 10.6.8.2. Israel: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.6.8.3. Israel: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  - 10.6.8.4. Israel: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  - 10.6.8.5. Israel: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
- 10.6.9. Direct Oral Anticoagulants (DOACs) Device Market - South Africa
  - 10.6.9.1. South Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  - 10.6.9.2. South Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.6.9.3. South Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  - 10.6.9.4. South Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  - 10.6.9.5. South Africa: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
- 10.6.10. Direct Oral Anticoagulants (DOACs) Device Market - Rest of Middle East & Africa
  - 10.6.10.1. Rest of Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  - 10.6.10.2. Rest of Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.6.10.3. Rest of Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  - 10.6.10.4. Rest of Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  - 10.6.10.5. Rest of Middle East & Africa: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
10.7. Direct Oral Anticoagulants (DOACs) Device Market - Latin America
- 10.7.1. Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
- 10.7.2. Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
- 10.7.3. Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
- 10.7.4. Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
- 10.7.5. Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
- 10.7.6. Direct Oral Anticoagulants (DOACs) Device Market - Mexico
  - 10.7.6.1. Mexico: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  - 10.7.6.2. Mexico: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.7.6.3. Mexico: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  - 10.7.6.4. Mexico: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  - 10.7.6.5. Mexico: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
- 10.7.7. Direct Oral Anticoagulants (DOACs) Device Market - Brazil
  - 10.7.7.1. Brazil: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  - 10.7.7.2. Brazil: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.7.7.3. Brazil: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  - 10.7.7.4. Brazil: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  - 10.7.7.5. Brazil: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
- 10.7.8. Direct Oral Anticoagulants (DOACs) Device Market - Argentina
  - 10.7.8.1. Argentina: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  - 10.7.8.2. Argentina: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.7.8.3. Argentina: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  - 10.7.8.4. Argentina: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  - 10.7.8.5. Argentina: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)
- 10.7.9. Direct Oral Anticoagulants (DOACs) Device Market - Rest of Latin America
  - 10.7.9.1. Rest of Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by Product Type, 2020-2034 (USD Billion)
  - 10.7.9.2. Rest of Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by Disease Indication, 2020-2034 (USD Billion)
  - 10.7.9.3. Rest of Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by Application, 2020-2034 (USD Billion)
  - 10.7.9.4. Rest of Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by Patient Demographic, 2020-2034 (USD Billion)
  - 10.7.9.5. Rest of Latin America: Direct Oral Anticoagulants (DOACs) Device Market, by End User, 2020-2034 (USD Billion)

11. Competitive Landscape

11.1. Expansion and Acquisition Analysis
- 11.1.1. Expansion
- 11.1.2. Acquisitions
11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

12.1. Siemens Healthineers
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Benchmarking
- 12.1.4. Recent Development
12.2. Abbott Laboratories
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Benchmarking
- 12.2.4. Recent Development
12.3. Roche Diagnostics
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Benchmarking
- 12.3.4. Recent Development
12.4. Sysmex Corporation
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Benchmarking
- 12.4.4. Recent Development
12.5. Instrumentation Laboratory (Werfen)
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Benchmarking
- 12.5.4. Recent Development
12.6. Nihon Kohden Corporation
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product Benchmarking
- 12.6.4. Recent Development
12.7. Diagnostica Stago
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product Benchmarking
- 12.7.4. Recent Development
12.8. Coag-Sense
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product Benchmarking
- 12.8.4. Recent Development
12.9. HemoSonics
- 12.9.1. Company Overview
- 12.9.2. Financial Performance
- 12.9.3. Product Benchmarking
- 12.9.4. Recent Development
12.10. Sekisui Medical Co., Ltd.
- 12.10.1. Company Overview
- 12.10.2. Financial Performance
- 12.10.3. Product Benchmarking
- 12.10.4. Recent Development
12.11. Grifols S.A.
- 12.11.1. Company Overview
- 12.11.2. Financial Performance
- 12.11.3. Product Benchmarking
- 12.11.4. Recent Development
12.12. Helena Laboratories Corporation
- 12.12.1. Company Overview
- 12.12.2. Financial Performance
- 12.12.3. Product Benchmarking
- 12.12.4. Recent Development